Anticoagulation in Patients with Atrial High-rate Episodes Detected by Cardiac Implantable Electronic Devices
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
Atrial high-rate episodes (AHRE) are atrial tachyarrhythmias that are identified by the use of continuous rhythm monitoring devices such as pacemakers, defibrillators, or implantable cardiac monitors. Nevertheless, the therapeutic implications of these rhythm disturbances remain uncertain. The presence of AHRE is associated with an increased risk of stroke as compared to patients who do not exhibit AHRE. The utilisation of oral anticoagulation has the ability to mitigate the likelihood of stroke occurrence in patients with AHRE. However, it is important to note that this treatment approach is also linked to a severe bleeding rate of approximately 2% per year. The stroke rate among individuals diagnosed with AHRE appears to be comparatively lower when compared to patients diagnosed with atrial fibrillation. The efficacy and safety of anticoagulation in patients with AHRE have yet to be definitively established. Further research is required to provide a comprehensive understanding of the effectiveness and safety of oral anticoagulation in individuals with AHRE.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
Current pharmaceutical design - (2024) vom: 09. Feb. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Spartalis, Michael [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anticoagulation |
---|
Anmerkungen: |
Date Revised 12.02.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.2174/0113816128291822240131063712 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM36833208X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM36833208X | ||
003 | DE-627 | ||
005 | 20240213233029.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240213s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2174/0113816128291822240131063712 |2 doi | |
028 | 5 | 2 | |a pubmed24n1291.xml |
035 | |a (DE-627)NLM36833208X | ||
035 | |a (NLM)38343055 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Spartalis, Michael |e verfasserin |4 aut | |
245 | 1 | 0 | |a Anticoagulation in Patients with Atrial High-rate Episodes Detected by Cardiac Implantable Electronic Devices |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 12.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
520 | |a Atrial high-rate episodes (AHRE) are atrial tachyarrhythmias that are identified by the use of continuous rhythm monitoring devices such as pacemakers, defibrillators, or implantable cardiac monitors. Nevertheless, the therapeutic implications of these rhythm disturbances remain uncertain. The presence of AHRE is associated with an increased risk of stroke as compared to patients who do not exhibit AHRE. The utilisation of oral anticoagulation has the ability to mitigate the likelihood of stroke occurrence in patients with AHRE. However, it is important to note that this treatment approach is also linked to a severe bleeding rate of approximately 2% per year. The stroke rate among individuals diagnosed with AHRE appears to be comparatively lower when compared to patients diagnosed with atrial fibrillation. The efficacy and safety of anticoagulation in patients with AHRE have yet to be definitively established. Further research is required to provide a comprehensive understanding of the effectiveness and safety of oral anticoagulation in individuals with AHRE | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Anticoagulation | |
650 | 4 | |a Atrial fibrillation | |
650 | 4 | |a Cardiac device | |
650 | 4 | |a Pacemaker | |
650 | 4 | |a Stroke | |
650 | 4 | |a prevention | |
700 | 1 | |a Kontogiannis, Christos |e verfasserin |4 aut | |
700 | 1 | |a Spartalis, Eleftherios |e verfasserin |4 aut | |
700 | 1 | |a Iliopoulos, Dimitrios C |e verfasserin |4 aut | |
700 | 1 | |a Siasos, Gerasimos |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current pharmaceutical design |d 1998 |g (2024) vom: 09. Feb. |w (DE-627)NLM095430172 |x 1873-4286 |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:09 |g month:02 |
856 | 4 | 0 | |u http://dx.doi.org/10.2174/0113816128291822240131063712 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 09 |c 02 |